Back

Beta-blockers vs amiodarone in management of new onset atrial fibrillation in patients receiving critical care services: an analysis from a global federated research network

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: New-onset atrial fibrillation: risk prediction, clinical management, and outcomes Acute Management ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Koohyar Ahmadzadeh

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Ethnic differences in new-onset atrial fibrillation using multidimensional data
Doctor H. Naderi (London, GB)
Abstract
Presentation thumbnail
Hepatic steatosis and incident cardiovascular events in patients with new-onset atrial fibrillation
Doctor S. Sohn (Seoul, KR)
Abstract
Presentation thumbnail
Predicting new-onset atrial fibrillation after transcatheter aortic valve implantation using the FIND-AF machine learning algorithm
Doctor J. Tan (Leeds, GB)
Abstract
Presentation thumbnail
Shifting clinical landscape of wild-type transthyretin amyloid cardiomyopathy: earlier detection, milder cardiac involvement, and reduced new-onset of atrial fibrillation in the contemporary era
Doctor H. Kondo (Yufu City, JP)
Abstract
Presentation thumbnail
Development and external validation of a pre-operative prediction model for new-onset atrial fibrillation after coronary artery bypass grafting
Miss W. Li (Exeter, GB)
Abstract

Access the full session

Session thumbnail
New-onset atrial fibrillation: risk prediction, clinical management, and outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
New-onset atrial fibrillation in the ICU: a temporary disturbance or a lasting burden?
21 March 2026
thumbnail
Congress Presentation
Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy.
27 August 2021
thumbnail
Congress Presentation
Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
18 April 2023
thumbnail
Congress Presentation
Use of landiolol for acute heart rate management in critically ill cardiac patients: a retrospective single-center experience
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources